Progressive Supranuclear Palsy (PSP)
from OrphaChat — a Rare Disease Podcast Hosted by RCH
These sources provide a comprehensive look at atypical parkinsonian syndromes, specifically Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Corticobasal Degeneration (CBD). They highlight the clinical challenges in distinguishing these rare conditions from Parkinson’s disease, noting "red flags" like early falls, eye movement disorders, and poor response to levodopa. Advanced diagnostic tools are explored, including MRI signs like the "hummingbird" effect, blood tests for neurofilament light chain proteins, and specific genetic markers. While multidisciplinary care remains the standard for managing symptoms, the texts report the disappointing failure of the AMX0035 drug program to meet its primary goals. Current research continues through national clinical trial platforms and the development of innovative tau-targeting therapies to address the high level of unmet medical need. Progress is further supported by international patient registries and support networks dedicated to improving the quality of life for those affected.
Embed this episode
No transcript yet.